2nd & 3rd November 2022
Park Regis Hotel, Birmingham

This promotional meeting is organised and funded by Novartis Pharmaceuticals UK Limited and is intended for UK Healthcare professionals only.

UK | October 2022 | 245281

​

Adverse events should be reported. Reporting forms and information can be found at  www.mhra.gov.UK/yellowcard (UK). (By clicking this link you will leave the Novartis-associated website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.)

Adverse events should also be reported to Novartis via  uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at  www.report.novartis.com

If you have a question about a product, please contact Medical Information on 01276 698370 or by email at  medinfo.uk@novartis.com

​

To learn about your data privacy rights and the use of your personal information, we invite you to read our General Privacy Notice for Business Partners.

​

Indications: Treatment of: moderate to severe plaque psoriasis in adults, children and adolescents from the age of 6 years who are candidates for systemic therapy; active psoriatic arthritis in adults (alone or in combination with methotrexate) who have responded inadequately to disease-modifying anti-rheumatic drug therapy; active ankylosing spondylitis in adults who have responded inadequately to conventional therapy; active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to non-steroidal anti-inflammatory drugs.

​

1. Cosentyx Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/3669/smpc (Accessed October 2021). (By clicking this link you will leave the Novartis-associated website. This link will take you to a website to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.)